Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutriagaves Group is a prominent Mexican company specializing in the development and manufacture of high-quality functional ingredients derived from Blue Agave. The company is a global leader in the production of organic agave syrup and agave inulin, a highly soluble prebiotic fiber marketed under the brand name Olifructine. These products are designed to serve the nutraceutical, food, and beverage industries as low-glycemic sweeteners and digestive health enhancers. Nutriagaves manages a vertically integrated supply chain, overseeing everything from the cultivation of agave in Jalisco to advanced extraction and spray-drying processes. Their agave inulin is clinically recognized for its ability to promote the growth of beneficial gut bacteria and improve metabolic health. The company maintains a strong commitment to sustainability and holds various international certifications, including USDA Organic and Non-GMO Project Verified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutriagaves Group.